A comparison of performance of anti-cyclic citrullinated peptide 2 and citrullinated protein antibodies in the diagnosis of rheumatoid arthritis in Iranian patients

被引:0
作者
Elham Aflaky
Saeedeh Shenavandeh
Mohammad Javad Ashraf
机构
[1] Shiraz University of Medical Sciences,Division of Rheumatology, Department of Internal Medicine, Medical School
[2] Shiraz University of Medical Sciences,Department of Pathology, Medical School
来源
Rheumatology International | 2010年 / 30卷
关键词
Arthritis; Rheumatoid; Rheumatoid factor; Anti-cyclic citrullinated peptide 2; Citrullinated protein antibody;
D O I
暂无
中图分类号
学科分类号
摘要
Antibodies to citrullinated proteins and rheumatoid factor (RF) are widely used in patients with rheumatoid arthritis (RA) and the antibodies to citrullinated proteins appear to be the most specific markers of the disease. The objective was to compare the diagnostic performance of the anti-cyclic citrullinated peptide 2 (anti-CCP2) and citrullinated protein Antibodies (CPA) with RF in the diagnosis of RA. Serum samples of 139 patients with RA and 131 patients with other rheumatic diseases were checked for anti-CCP2, CPA uses citrullinated recombinant rat filaggrin as the antigen assay, and RF. The specificity, sensitivity, and receiver operating characteristic (ROC) of tests were then compared. The sensitivity of anti-CCP2, CPA, and RF were 82.7, 83.5, and 61.5%, respectively. The specificities of the tests were 91.2, 78.6, and 90.5%, respectively. The area under ROC curves for the tests were 0.925, 0.890, and 0.847, respectively. Exclusion of overlaps was associated with improved specificity for CPA but no change in the specificity of RF and anti-CCP. The sensitivity of anti-CCP2, CPA, and RF were 66.7, 77.8, and 51.9% for patients with early RA, respectively. The findings of the present study indicate that anti-CCP2 might be of a better diagnostic value for the diagnosis of RA. They also showed that CPA and in the second place anti-CCP2 were useful in the diagnosis of early RA.
引用
收藏
页码:461 / 466
页数:5
相关论文
共 50 条
[41]   Anti-cyclic citrullinated peptide and rheumatoid factor in HIV positive patients [J].
Zeljko Romic ;
Lovorka Derek ;
Vitomir Burek ;
Adriana Unic ;
Tihana Serdar ;
Domagoj Marijancevic ;
Jadranka Morovic-Vergles ;
Josko Mitrovic ;
Mladen Petrovecki .
Rheumatology International, 2011, 31 :1607-1610
[42]   Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: Relation with disease aggressiveness [J].
Del Val Del Amno, N. ;
Bosch, R. Ibanez ;
Manteca, C. Fito ;
Polo, R. Gutierrez ;
Cortina, E. Loza .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (03) :281-286
[43]   Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis [J].
Lutteri, Laurence ;
Malaise, Michel ;
Chapelle, Jean-Paul .
CLINICA CHIMICA ACTA, 2007, 386 (1-2) :76-81
[44]   Differentiation of Rheumatoid Arthritis From HCV Infection: Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide or Anti-Mutated Citrullinated Vimentin? [J].
Kaptanoglu, Ece ;
Nadir, Isilay ;
Bakici, Zahir ;
Hayta, Emrullah ;
Turkmen, Mehmet ;
Sezer, Hafize ;
Hizmetli, Sami ;
Elden, Hasan .
TURKISH JOURNAL OF RHEUMATOLOGY, 2010, 25 (01) :19-23
[45]   Clinical Significance of Combined Anti-Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor Assays in Rheumatoid Arthritis Diagnosis [J].
Cao, Qingmei ;
Wang, Yanfeng ;
Jing, Yuanyuan .
ARCHIVES OF RHEUMATOLOGY, 2015, 30 (02) :104-108
[46]   The association of immunoglobulin A, immunoglobulin G and anti-cyclic citrullinated peptide antibodies with disease activity in seronegative rheumatoid arthritis patients [J].
Karimifar, Mansoor ;
Moussavi, Hamidreza ;
Babaei, Mehran ;
Akbari, Mojtaba .
JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 (09) :823-826
[47]   A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis [J].
Cho, Sun Young ;
Kang, So Young ;
Lee, Hee Joo ;
Lee, Woo In .
KOREAN JOURNAL OF LABORATORY MEDICINE, 2008, 28 (01) :39-45
[48]   Anti-cyclic citrullinated peptide antibody and pain sensitisation in patients with rheumatoid arthritis: a cross-sectional analysis [J].
Qiu, Yoon Y. ;
Neogi, Tuhina ;
Muhammad, Lutfiyya N. ;
Song, Jing ;
Bolster, Marcy B. ;
Marder, Wendy ;
Heisler, Andrew C. ;
Wohlfahrt, Alyssa ;
Dunlop, Dorothy ;
Lee, Yvonne C. .
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (12) :1638-1640
[49]   Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients [J].
Sulaiman, Farah Nadiah ;
Wong, Kah Keng ;
Ahmad, Wan Aireene Wan ;
Ghazali, Wan Syamimee Wan .
MEDICINE, 2019, 98 (12)
[50]   Anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with idiopathic inflammatory myopathy [J].
Labrador-Horrillo, Moises ;
Angeles Martinez, M. ;
Selva-OCallaghan, Albert ;
Francisco Delgado, Juan ;
Martinez-Gomez, Xavier ;
Trallero-Araguas, Ernesto ;
Luis Rodriguez-Sanchez, Jose ;
Vilardell-Tarres, Miquel .
RHEUMATOLOGY, 2009, 48 (06) :676-679